Northwestern Mutual Investment Management Company’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
BPC
MC
Northwestern Mutual Investment Management Company's MRNA Position: Q2 2026 in Review
Northwestern Mutual Investment Management Company increased its Moderna (MRNA) stake by 1.8% in Q2 2026, buying an estimated $10.1K and bringing the position to 11,322 shares worth $793K. The position accounts for 0.01% of the portfolio, ranked #695.
Northwestern Mutual Investment Management Company first reported a position in MRNA in Q3 2021 and has held it in 20 quarters since. The position peaked at $6.14M in Q3 2021. 542 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.
- Northwestern Mutual Investment Management Company held 11,322 shares of Moderna worth $793K as of Q2 2026.
- Northwestern Mutual Investment Management Company bought 195 Moderna shares in Q2 2026, an estimated $10.1K.
- Moderna made up 0.01% of Northwestern Mutual Investment Management Company's portfolio in Q2 2026, its #695 holding.
- Northwestern Mutual Investment Management Company first reported a position in Moderna in Q3 2021 and has held it in 20 quarters since.
- Northwestern Mutual Investment Management Company's Moderna position peaked at $6.14M in Q3 2021.
- 542 funds tracked by Wall St. Rank held Moderna as of Q2 2026.
Based on Northwestern Mutual Investment Management Company's 13F filing for Q2 2026, filed 12 Aug 2026.